165 related articles for article (PubMed ID: 38317267)
1. Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family.
Wang Y; Chang Y; Gao M; Zang W; Liu X
Hereditas; 2024 Feb; 161(1):8. PubMed ID: 38317267
[TBL] [Abstract][Full Text] [Related]
2. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.
Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J
BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173
[TBL] [Abstract][Full Text] [Related]
3. Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism.
Jiang B; Zhang H; Kan Y; Gao X; Du Z; Liu Q
Mol Genet Genomic Med; 2024 Jan; 12(1):e2297. PubMed ID: 37882226
[TBL] [Abstract][Full Text] [Related]
4. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
5. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
6. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
8. Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families.
Zaman Q; Khan J; Ahmad M; Khan H; Chaudhary HT; Rehman G; Rahman OU; Shah MM; Hussain J; Jamal Q; Khan BT; Khan MA; Sadeeda ; Sahar K; Idrees M; Ahmad R; Faisal MS; Khan MI; Khisroon M; Abdulkareem AA; Lee E; Ryu SW; Bibi N; Muthaffar OY; Jelani M; Naseer MI
Gene; 2024 Feb; 894():147986. PubMed ID: 37956964
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
[TBL] [Abstract][Full Text] [Related]
10. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
11. Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.
Xu B; Chen X; Li H
Altern Ther Health Med; 2023 Oct; 29(7):278-283. PubMed ID: 37471664
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
13. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
14. Genetic analyses of Vietnamese patients with oculocutaneous albinism.
Thuong MTH; Anh LTL; Nhung VP; Ngoc TTB; Lan HT; Phuong DK; Ha NH; Van Hai N; Ton ND
J Clin Lab Anal; 2022 Sep; 36(9):e24625. PubMed ID: 35870188
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.
Zhong Z; Gu L; Zheng X; Ma N; Wu Z; Duan J; Zhang J; Chen J
Pigment Cell Melanoma Res; 2019 Sep; 32(5):672-686. PubMed ID: 31077556
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic characterization of Congolese patients with oculocutaneous albinism.
Laetitia MM; Veronique K; Mamy NZ; Cathy SM; Aimé L; Race V; Prosper LT; Devriendt K
Eur J Med Genet; 2022 Nov; 65(11):104611. PubMed ID: 36116698
[TBL] [Abstract][Full Text] [Related]
17. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
19. Current landscape of Oculocutaneous Albinism in Japan.
Okamura K; Suzuki T
Pigment Cell Melanoma Res; 2021 Mar; 34(2):190-203. PubMed ID: 32969595
[TBL] [Abstract][Full Text] [Related]
20. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]